SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Corixa [CRXA] - cancer vaccines
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
222 31 0 CRXA
Emcee:  Andreas Helke Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
172SEATTLE--(BUSINESS WIRE)--Jan. 13, 2003--Corixa Corporation (Nasdaq: CRXA - Newsnigel bates-1/13/2003
171SEATTLE & STAMFORD, Conn.--(BUSINESS WIRE)--Jan. 8, 2003--Corixa Corporationnigel bates-1/8/2003
170In the dark days CEPH sold off with Provigil approval... it's since gone strLLCF-1/4/2003
169David, it crapped out with a recommendation to approve. A market sell-off wouldMicawber-1/4/2003
168Bought some today... trying not to get too attached, this market sucks and anythLLCF-1/3/2003
167Merrill Lynch (Eric Ende) on IDPH Message 18348609sim1-12/18/2002
166Yeeeee-haaah!!!Harold Engstrom-12/17/2002
165US FDA panel backs Corixa's Bexxar for lymphoma Tuesday December 17, 8:20 pSemiBull-12/17/2002
164GSK/Corixa Likely To Emphasize Bexxar’s Durability Of Rsim1-12/14/2002
163SEATTLE--(BUSINESS WIRE)--Dec. 4, 2002--Corixa Corporation (Nasdaq:CRXA - News),nigel bates-12/4/2002
162FDA plan for Bexxar raises Corixa shares BLOOMBERG NEWS sim1-12/3/2002
161BEXXAR Update: FDA returns Bexxar to active review status: biz.yahoo.com PressRCMac-12/2/2002
160ASH Abstract: BEXXAR Produces a Substantial Number of Durable Complesim1-11/25/2002
159Corixa says FDA Panel to Review Bexxar Tuesday November 5, 2:18 pm ET SEATTLESemiBull-11/5/2002
158Corixa Announces $45 M Private Placement Financing SEATTLE -(Dow Jones)- CorixaSemiBull-8/12/2002
157Corixa Reports Second Quarter Results SEATTLE--(BW HealthWire)--Aug. 8, 2002--CSemiBull-8/8/2002
156FDA Grants Corixa's Appeal For BEXXAR Corixa to Present BEXXAR Data at Futusim1-6/27/2002
155Coley (and crxa). Established Human Papillomavirus Type 16-Expressing Tumors Arkeokalani'nui-6/21/2002
154Corixa Announces the Initiation of Additional PVAC Treatment U.S. Clinical TrialSemiBull-6/6/2002
153Corixa Files Request for Formal Dispute Resolution With FDA on BEXXAR In its Apsim1-5/31/2002
152Corixa Announces Restructuring of Its South San Francisco Operations Company tonigel bates-5/23/2002
151SEATTLE, and PRINCETON, N.J., May 23 /PRNewswire-FirstCall/ -- Medarex Inc. (Nasnigel bates-5/23/2002
150Introgen's Anti-Cancer INGN 241 Yields Positive Results AUSTIN , Texas -(DoSemiBull-5/22/2002
149Corixa Reports First Quarter 2002 Results and Provides Update On Select ProgramsSemiBull-5/15/2002
148Corixa/Bexxar -2: 3rd Time In 3 Months FDA Questions Drug SEATTLE -(Dow Jones)-SemiBull-5/15/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News